Stonehage Fleming Financial Services’s Boston Scientific BSX Stock Holding History

Stonehage Fleming Financial Services’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,759	Closed	-$289K	–	223
2024 Q2	$289K	Buy	+3,759	New	+$275K	0.01%	120
2020 Q1	–	Sell	-1,000	Closed	-$45K	–	179
2019 Q4	$45K	Buy	+1,000	New	+$41.8K	﹤0.01%	157
2017 Q1	–	Sell	-6,000	Closed	-$143K	–	276
2016 Q4	$143K	Hold	6,000	–	–	0.01%	228
2016 Q3	$143K	Hold	6,000	–	–	0.01%	214
2016 Q2	$140K	Hold	6,000	–	–	0.01%	211
2016 Q1	$113K	Buy	+6,000	New	+$105K	0.01%	248

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Stonehage Fleming Financial Services's BSX Position: Q3 2024 in Review

Stonehage Fleming Financial Services sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 3,759 shares — an estimated $289K sold.

Stonehage Fleming Financial Services first reported a position in BSX in Q1 2016 and held it in 6 quarters. The position peaked at $289K in Q2 2024. 1,400 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

Stonehage Fleming Financial Services reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
Stonehage Fleming Financial Services sold 3,759 Boston Scientific shares in Q3 2024, an estimated $289K.
Stonehage Fleming Financial Services first reported a position in Boston Scientific in Q1 2016 and held it in 6 quarters.
Stonehage Fleming Financial Services's Boston Scientific position peaked at $289K in Q2 2024.
1,400 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Stonehage Fleming Financial Services's 13F filing for Q3 2024, filed 8 Nov 2024.